CDC changes childhood vaccine schedule
Digest more
As a retired nurse with decades of experience on the front lines of health care, I have witnessed firsthand the incredible impact that vaccinations have on children’s health and well-being. Throughout my career, I cared for countless young patients, and ...
May 30, 2025 – The FDA has approved the first-ever meningococcal vaccine for babies as young as 6 weeks old. Sanofi Pasteur’s quadrivalent MenQuadfi shot was first cleared in 2020 for adults and children ages 2 years or older. It protects against ...
More than 80% of US adolescents received at least one dose of the meningococcal vaccine MenACWY. However, uptake of its first dose and completion of the booster dose varied by race or ethnicity, household income, and maternal education, and some racial ...
The U.S. FDA has approved an expanded indication for Sanofi (NASDAQ:SNY)’s quadrivalent meningococcal vaccine, MenQuadfi, now allowing its use in children as young as 6 weeks old. Previously approved for individuals aged 2 years and older, MenQuadfi by ...
Please provide your email address to receive an email when new articles are posted on . A newly approved pentavalent meningococcal vaccine covers serogroups A, B, C, W and Y. A CDC advisory committee recommended administering it when both MenACWY and MenB ...
The US Food and Drug Administration has approved a meningococcal vaccine against the five most common serogroups causing disease in children and young adults. The new formulation called Penbraya is manufactured by Pfizer and combines the components from ...
"Identifying contributing factors to low vaccine uptake, such as the association between local deprivation and uptake of meningococcal vaccines, should be of public health importance and acknowledged by local governments and policy makers in their efforts ...
Please provide your email address to receive an email when new articles are posted on . Penmenvy protects against meningococcal serotypes A, B, C, W and Y. CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved ...